| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |